The invention provides methods for delivering interfering RNA molecules toan eye of a patient to treat ocular disorders. In particular, the methods of theinvention comprise the use of a self-complementary adeno-associated (scAAV)viral vector that can deliver an interfering RNA molecule to an eye of a patientto inhibit expression of a gene that is associated with an ocular disorder.